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Pulmonary Granulomas 
in an Intravenous Drug User
 
A 28-year-old woman with a history of heroin use was ad-
mitted for increasing dyspnea. A chest radiograph (Panel A) 
showed diffuse bilateral pulmonary infiltrates that were pre-
dominantly interstitial. An open-lung biopsy was per-
formed. Histologic analysis showed medial hypertrophy of 
medium-sized pulmonary arteries indicative of pulmonary 
hypertension, as well as occasional foreign-body granulo-
mas. Polarized light microscopy (Panel B) revealed refractile 
particles in the outer portion of the wall of a pulmonary ar-
tery (hematoxylin and eosin, ¬40). Electron microscopy of 
lung tissue showed the ultrastructural aspects of the embo-
lized microcrystalline material in an alveolar septum (arrow 
in Panel C, ¬2100; Panel D, ¬6600). In intravenous drug 
users, pulmonary granulomatosis is due to the repeated for-
mation of microemboli of foreign material resulting from 
the injection of suspensions of crushed tablets or the con-
tents of capsules intended for oral consumption. The for-
eign material consists of insoluble microcrystals (cellulose, 
talc, or starch) used as inert filler substances in oral pharma-
ceutical preparations such as methadone and barbiturates. 
There is no specific treatment for granulomatous lung dis-
ease related to intravenous drug use.
The open-lung biopsy was complicated by a pneumotho-
rax. Progressive respiratory failure subsequently devel-
oped, and the patient died four weeks later.
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